Systemic inflammatory response syndrome in Sepsis-3: a retrospective study
BMC Infectious Diseases volume 19, Article number: 139 (2019)
In the new Sepsis-3 definition, sepsis is defined as “life-threatening organ dysfunction due to a dysregulated host response to infection.” We tested the predictive validity of the systematic inflammatory response syndrome (SIRS) criteria in patients in the Sepsis-3 cohort.
Among 1243 electronic health records from 1 January to 31 December 2015 at Sichuan University West China Hospital, we identified patients with sepsis and septic shock according to the Sepsis-3 definition and divided them into 2 subsets: SIRS-positive and SIRS-negative. We compared their characteristics and outcomes as well as the predictive validity of the SIRS criteria for in-hospital mortality.
Of the 1243 patients, 631 were enrolled. Among these, 538 (85.3%) patients had SIRS-positive sepsis or septic shock, 168 (31.2%) of whom died, and 93 (14.7%) had SIRS-negative sepsis or septic shock, 20 (21.5%) of whom died (p = 0.06). Over a 1-year period, these groups had similar characteristics and changes in mortality. Among patients of the Sepsis-3 cohort admitted to the intensive care unit, the predictive validity for in-hospital mortality was lower for the SIRS criteria (area under the receiver operating characteristic curve [AUROC], 0.53; 95% confidence interval [95% CI], 0.49–0.57) than for the sequential (sepsis-related) organ failure assessment (SOFA) criteria (AUROC, 0.70; 95% CI, 0.66–0.74; p ≤ 0.01 for both). The SIRS score had poor predictive validity for the risk of in-hospital mortality.
In this cohort study of the new Sepsis-3 definition, we found that the SIRS criteria are weaker than the SOFA criteria with respect to their predictive efficacy for in-hospital death.
Despite considerable medical advances, sepsis is common and associated with high morbidity and mortality rates [1, 2]. In 1991, the Task Force in the First International Consensus Conference used expert opinion to generate the then-current definitions of sepsis (First International Consensus Conference Definitions for Sepsis and Septic Shock [Sepsis-1]) based on the presence of systematic inflammatory response syndrome (SIRS) . Because of high sensitivity and low specificity, Sepsis-1 was replaced by Sepsis-2 in 2001 . However, Sepsis-2 did not show superiority over Sepsis-1 in the diagnosis of sepsis . In 2015, a study of SIRS in patients with severe sepsis completely disclosed the flaws of the SIRS criteria, prompting further revision of the sepsis definition . In 2016, the Third International Consensus Conference established a new sepsis definition (Sepsis-3) . In Sepsis-3, the Sequential (Sepsis-related) Organ Failure Assessment (SOFA) criteria, rather than the SIRS criteria, are used as the basis for the definitions of sepsis and septic shock.
Since application of the SIRS criteria to the definition of sepsis during the past two decades, many clinicians have become ingrained in thinking that the pathophysiological condition progresses from SIRS to sepsis and septic shock and then to multiple organ failure [8,9,10]. However, sepsis is actually a syndrome of severe infection with a complicated pathogenesis beyond the scope of our recognition . Many experts and specialists have attempted to use the clinical criteria of SIRS to describe the pathophysiological process and nature of inflammatory syndromes caused by severe infection, but the outcomes have been unsatisfactory . A new definition of sepsis derived from a database of developed countries has been validated for use in these developed countries . However, it is necessary to be further validated for the concept whether can be generalized to developing countries. Certainly, some studies evaluated SEPSIS-3 in developing countries have aroused our attention [13, 14]. In the present study, we used data from developing countries to compare the SIRS criteria with the SOFA criteria to predict a high risk of in-hospital death among critically ill patients with sepsis according to the new definition.
Study design and setting
This retrospective study was conducted in a general intensive care unit (ICU) and included adult patients with sepsis or septic shock according to the Sepsis-3 definition from 1 January to 31 December 2015, using data from the Sichuan University West China Hospital Critical Care Medicine Sepsis-3 Database. This study was approved by the Ethics Committee of Sichuan University West China Hospital (No. 315, 2016). Due to the retrospective study design involving electronic health records and no additional interventions, written informed consent was not obtained from the patients or their relatives. This study was registered at the Chinese Clinical Trial Register (CCTR number: ChiCTR-ORC-16010138, registered 12 December 2016). URL: http://www.chictr.org.cn/showproj.aspx?proj=16715.
The inclusion criteria of the study were as follows:
Age of ≥18 years
A ≥ 24-h stay in the general ICU
The presence of infection or suspected infection, defined as follows : 1) The initial episode of suspected infection was identified through a combination of antibiotic treatment and body fluid cultures. 2) We required that the combination of antibiotics and culture sampling occurred within a specific time limit. If the culture sampling occurred first, antibiotic must have been administered within 72 h. If the antibiotic was administered first, the culture sampling must have been obtained within 24 h. 3) The onset of infection was defined as the time point at which the first of the two events (antibiotic treatment and culture sampling) took place.
Primary and secondary outcomes
In this study, we regarded SIRS-positive sepsis as the primary outcome and followed up all patients before hospital discharge using their medical records. All-cause in-hospital mortality was the secondary outcome.
Definition of cohorts
Indicators were generated for each component of the SIRS criteria  and SOFA score . We calculated the maximum SIRS criteria and SOFA score for the time window ranging from 48 h before to 24 h after the onset of infection. Organ dysfunction in patients with sepsis occurring before, near the moment of, or after infection is recognized by clinicians. Thus, for the candidate criteria, we used that time window. From up to 48 h before to up to 24 h after the onset of infection, we calculated changes of ≥2 points in the SOFA score [7, 12].
We defined sepsis or septic shock according to the Sepsis-3 definitions . Organ dysfunction can be identified as an acute change of ≥2 points in the total SOFA score consequent to the infection. The baseline SOFA score can be assumed to be 0 points in patients not known to have pre-existing organ dysfunction. Even patients presenting with modest dysfunction can deteriorate further, emphasizing the seriousness of this condition and the need for prompt and appropriate intervention if not already being instituted. Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. Patients with septic shock can be identified using a clinical construct of sepsis with persisting hypotension requiring vasopressors to maintain the mean arterial pressure at ≥65 mmHg and serum lactate concentration at > 2 mmol/L (18 mg/dL) despite adequate volume resuscitation.
Among the Sepsis-3 cohort, the SIRS-positive cohort was defined as patients with SIRS scores of ≥2 points, and the SIRS-negative cohort was defined as patients with SIRS scores of < 2 points, including those with scores of 0 points and 1 point .
We collected general information including medical identification numbers, demographic characteristics, vital signs, and laboratory test results from the medical records of patients upon admission to the ICU or during their stay in the ICU. We calculated the SIRS and SOFA scores for each patient using these data. Acute Physiology and Chronic Health Evaluation II (APACHE II)  scores were collected to assess the severity of illness among patients admitted to the ICU in the first 24 h.
Researchers who participated in data collection for the study were blinded to the study design, and the study designers did not participate in the data collection.
Data are presented as number and percentage, mean and standard deviation, median and interquartile range, or proportion with 95% confidence interval. The chi-square test for equal proportion, Student’s t-test, or the Wilcoxon rank-sum test was used to test differences. No assumptions were made for missing data, and multivariable analyses were performed for patients with complete data.
To identify independent differences at baseline that may have existed between patients with SIRS-positive sepsis and SIRS-negative sepsis, we applied multivariable logistic regression to the data from all patients with severe sepsis with a SIRS-positive status as the outcome. To further determine the predictive capacity of using two or more SIRS criteria to identify an increase in the risk of death, SIRS was considered first as a dichotomous variable (≥2 SIRS criteria vs. 0 to 1 SIRS criterion) and second as an ordinal variable from 0 to 4, reflecting the number of SIRS criteria met. To determine whether predictors of death differed significantly between SIRS-positive sepsis and SIRS-negative sepsis, we created a multivariable logistic regression model for mortality among all patients with sepsis. All statistical analyses were performed using MedCalc® (version 15.8) statistical software  and Empower Stats software . All statistical tests were two-tailed, and p < 0.05 was considered significant.
Study cohort characteristics
A flow diagram of the study is shown in Fig. 1. As described in the Methods section, 1243 patients were evaluated in the enrollment period and 873 patients had complete clinical data. We finally enrolled 631 patients with sepsis or septic shock according to the Sepsis-3 definition. In total, 370 patients were excluded because of a < 24-h ICU length of stay (n = 247), secondary admission to the ICU (n = 121), and an age of < 18 years (n = 2). Of 538 patients enrolled in the.
SIRS-positive cohort, 168 (31.2%) died, and of 93 patients enrolled in the SIRS-negative cohort, 20 (21.5%) died; the outcome of pairwise assessment revealed no significant difference (p = 0.06). There were no missing data.
The patients’ baseline characteristics are listed in Table 1. The patients’ age was higher in the SIRS-negative cohort than in the SIRS-positive cohort (p = 0.011). The SIRS scores were higher in the positive than negative cohort. The median APACHE II score for all patients upon ICU arrival was 25. SOFA scores were available for 631 patients, and the median was 9. The SOFA and APACHE II scores were not significantly different between the two cohorts. The median length of ICU stay was 13 days (range, 7–24 days); it was also 13 days in the SIRS-positive and -negative cohorts separately, and pairwise comparison showed no significant difference (p = 0.622). The median length of hospital stay was 22 days (range, 12.5–35 days); it was 22 and 20 days in the SIRS-positive and -negative cohorts, respectively, and pairwise comparison showed no significant difference (p = 0.569). The proportion of male patients was 66.1% (417 of 631), and there was no significant difference in the proportion of male patients between the SIRS-positive and -negative cohorts (p = 0.412). The median 28-day of ventilator-free days and the duration of continuous renal replacement therapy were 8 and 10 days, respectively, with no significant differences between the two SIRS cohorts. The rates of mechanical ventilation and continuous renal replacement therapy in patients with sepsis were not significantly different between the cohorts (both p > 0.05). However, the rate of septic shock in patients with sepsis was higher in the SIRS-positive than SIRS-negative cohort (p = 0.044).
Distribution of hospital mortality
The distributions of hospital mortality according to the SIRS score and subsets of the new Sepsis-3 definition are shown in Fig. 2. An increasing trend of hospital mortality with increasing SIRS scores was not evident (p > 0.05) (Fig. 2a). This held true for both the SIRS-positive and -negative cohorts (Fig. 2b). However, the distribution of hospital mortality was higher in the subgroups of patients with septic shock than in the subgroups of patients with sepsis (p < 0.001) (Fig. 2c). Among all age interval subgroups, the fold changes (ratio) of hospital mortality (SIRS score of ≥2 vs. < 2) were higher in the intervals of 3, 6, and 7 than in the other intervals (Fig. 3).
SIRS in new Sepsis-3 definition
The distributions of signs meeting the SIRS criteria are shown in Table 2. The most frequent SIRS criterion that was met in patients with SIRS-positive sepsis was an increased heart rate, followed by an increased respiratory rate or a low partial pressure of arterial carbon dioxide and an abnormal white cell count. As in the patients with SIRS-positive sepsis, the most frequent single criterion that was met in patients with SIRS-negative sepsis was an increased heart rate (Table 2). Of patients with SIRS-negative sepsis, 17.2% fulfilled no SIRS criteria, and 82.8% fulfilled one SIRS criterion (Table 2).
Multivariate logistic regression analysis
The outcomes of the multivariate logistic regression analysis of hospital mortality and SIRS positivity are shown in Table 3. The risk factors for hospital mortality, including the APACHE II score, length of hospital stay, length of ICU stay, 28-day mechanical ventilation, rate of mechanical ventilation, administration of vasopressors, and SOFA score, were statistically significant (p < 0.05). The risk factors for SIRS positivity, including the SOFA score and hospital length of stay, were also statistically significant (p < 0.05).
The areas under the receiver operating characteristic curves (AUROCs) for the baseline risk model (age for mortality), SIRS, SOFA score, and APACHE II score are shown in Fig. 4. The AUROC for the SIRS model was 0.53 for prediction of hospital mortality; this was much lower than those for the baseline risk model, APACHE II score, and SOFA score (SIRS vs. age: 0.53 vs. 0.62, p < 0.01; SIRS vs. APACHE II: 0.53 vs. 0.73, p < 0.01; SIRS vs. SOFA: 0.53 vs. 0.70, p < 0.01).
In the present study, we found that the SIRS criteria had poor predictive validity for hospital mortality in critically ill patients with sepsis compared with the SOFA criteria under the new Sepsis-3 definition.
Among ICU patients with sepsis according to the new Sepsis-3 definition, 85.3% had SIRS-positive sepsis or septic shock and 14.7% had SIRS-negative sepsis or septic shock. Using the SIRS assessment system as a screening tool, we may miss approximately one in six of patients with infections at a high risk of death; this suggests that the SIRS assessment system may be unfit for critically ill patients with infections in ICUs of developing countries. In 2015, Kaukonen et al. (6) reported that the use of two or more SIRS criteria to define severe sepsis excluded one in eight otherwise similar patients with infection, organ failure, and substantial mortality. In the present study, we found that by using the SIRS system, we may miss more than one in six patients with infections at high risk of death. The rate of exclusion of those patients with a high risk of death was higher than reported by Kaukonen et al. (6) because we included the subset of patients with septic shock rather than severe sepsis of the Sepsis-2 definition.
In the present investigation, the AUROC for SIRS was much lower than in the Kaukonen’s study of predicting hospital mortality in ICU patients with sepsis (6). One reason for the discrepancy may be that the severity of illness in the patients of the present study was greater than that in the study by Kaukonen et al. (6) (APACHE II scores of ≥24: 55.6% vs. 28.8%, respectively).
Discrimination of hospital mortality using SIRS was much lower than that using SOFA. With respect to discrimination of hospital mortality using SIRS, we found that the AUROC was much lower than that for SOFA.
Our study has several strengths. First, the study is recent, making the data current and relevant. Second, it investigated the effect of the SIRS criteria within the time window of the initial episode of suspected infection during the ICU stay on the diagnosis of sepsis over a period of 1 year. Third, and most importantly, the SIRS data consisted of physiological or laboratory measurements that were retrospectively collected for routine monitoring indicators and are therefore unlikely to be biased.
The first limitation of this study is that symptoms meeting the SIRS criteria were evaluated only during the episode of suspected infection in the ICU as recorded every 1 or 2 h on the observation charts. The second limitation is that we conducted a single-center clinical investigation in a province of southwest China; thus, the characteristics of our study population may lack representativeness. Multicenter prospective studies could address this issue. Finally, the third limitation is the high mortality rate, which had two main causes. First, as a large tertiary teaching hospital, our institution receives numerous patients with severe infections who have been transferred from smaller hospitals and primary healthcare institutions. Second, the limitations of the SOFA system in a retrospective cohort study played an important role in the high morbidity.
Despite the above-described limitations, we investigated the potential prognostic value of the SIRS criteria in a relatively high-risk population and found it to be different from the SOFA criteria.
In this cohort study of the new Sepsis-3 definition, we found that the SIRS criteria are weaker than the SOFA criteria with respect to their predictive efficacy for in-hospital death.
Acute physiology and chronic health evaluation score
Areas under the receiver operating characteristic curve
Chinese clinical trial register
Intensive care unit
Systematic inflammatory response syndrome
Sequential (sepsis-related) organ failure assessment
Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ. Hospital deaths in patients with sepsis from 2 independent cohorts. Jama. 2014;312:90–2.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, Sccm/Esicm/Accp/Ats/sis, (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Critical care medicine 31: 1250–1256.
Zhao H, Heard SO, Mullen MT, Crawford S, Goldberg RJ, Frendl G, Lilly CM. An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/surgical infection society sepsis definition. Crit Care Med. 2012;40:1700–6.
Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372:1629–38.
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M, Sepsis Definitions Task F. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus Definitions for Sepsis and septic shock (Sepsis-3). Jama. 2016;315:775–87.
Baue AE. MOF/MODS, SIRS: an update. Shock. 1996;6(Suppl 1):S1–5.
Afessa B. Systemic inflammatory response syndrome in patients hospitalized for gastrointestinal bleeding. Crit Care Med. 1999;27:554–7.
Fry DE. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg. 2012;78:1–8.
Rossaint J, Zarbock A. Pathogenesis of multiple organ failure in Sepsis. Crit Rev Immunol. 2015;35:277–91.
Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC. Assessment of clinical criteria for Sepsis: for the third international consensus Definitions for Sepsis and septic shock (Sepsis-3). Jama. 2016;315:762–74.
Besen B, Romano TG, Nassar AP Jr, Taniguchi LU, Azevedo LCP, Mendes PV, Zampieri FG, Park M. Sepsis-3 definitions predict ICU mortality in a low-middle-income country. Ann Intensive Care. 2016;6:107.
Machado FR, Assuncao MS, Cavalcanti AB, Japiassu AM, Azevedo LC, Oliveira MC. Getting a consensus: advantages and disadvantages of Sepsis 3 in the context of middle-income settings. Revista Brasileira de terapia intensiva. 2016;28:361–5.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.
Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9:591–7.
Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology. 2007;46:496–507.
Lin L, Chen CZ, Yu XD. The analysis of threshold effect using empower stats software. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2013;34:1139–41.
The authors thank Xiaoli He, Xiaolei Yang, Yangting Li, and Jie Yang for helping to construct the Sepsis-3 database at Sichuan University West China Hospital. The authors also thank all of the patients who participated in the clinical trial.
Consent to for publication
We received no specific funding for this study.
Availability of data and materials
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Due to the retrospective study design involving electronic health records and no additional interventions, written informed consent was not obtained from the participants, which was approved by the Ethics Committee of Sichuan University West China Hospital (No. 315, 2016).
(1) All authors have no relationships with companies that might have an interest in the submitted work over the previous 5 years; (2) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (3) none of the authors have nonfinancial interests that may be relevant to the submitted work.
There are no ethical/legal conflicts involved in the article.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, W., Zheng, Y., Feng, X. et al. Systemic inflammatory response syndrome in Sepsis-3: a retrospective study. BMC Infect Dis 19, 139 (2019). https://doi.org/10.1186/s12879-019-3790-0